SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies wins Patent Award in Silver category for the year 2011-12

29 Sep 2012 Evaluate

Venus Remedies, a leading research-based global pharmaceutical company has won the prestigious Patent Award in Silver category for the year 2011-12 in the valedictory function of India-Asia Pacific Pharma Business Meet, organized by Pharmexcil in Hyderabad.

The company has won this prestigious award for the second year in a row for its commendable contributions towards Research & Development, demonstrated by patent grants in 2011-12.

Venus Remedies has received four patents in this fiscal year with two patents each for Sulbactomax and Vancoplus. These patent grants from USA, Japan, Australia and New Zealand would augment company’s business plans in these countries. Till now, the company has received more than 80 patents for its various novel research formulations covering 51 countries across the globe.

Venus Remedies has established its presence across the world through a portfolio of more than 75 injectables and 13 patent protected novel research products catering to the critical care segment and super specialty segments. The company has special focus towards the growing epidemic of Antimicrobial Resistance and Oncology. Besides this, the company has 51 product registrations in the regulated markets with 108 CTDs filed for seven products and 400+ market authorizations in the emerging countries.

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×